Innovative test from Beckman Coulter helps clinicians better personalise IVF treatments

15 Jun 2021

Read More
Access AMH Advanced helps clinicians predict poor ovarian response
 
Contact Beckman Coulter (UK) Ltd
 

Related Articles

Beckman Coulter’s DxA 5000 Fit

Workflow automation for medium-sized labs

Added: 8 May 2021

Beckman Coulter has launched the first workflow automation solution for medium-sized laboratories i…

IL-6 assay aids in care management by determining patients at risk for intubation with mechanical ventilation

Interleukin-6 can help identify severe inflammatory response in COVID-19 patients

Added: 10 Mar 2021

Beckman Coulter has expanded claims for its CE-marked Access Interleukin-6 (IL-6) assay, which aids…

Beckman Coulter has launched its Access SARS-CoV-2 IgG II assay

Beckman Coulter launches SARS-CoV-2 IgG II antibody test in countries accepting CE Mark

Added: 16 Feb 2021

Beckman Coulter has launched its Access SARS-CoV-2 IgG II assay in countries accepting the CE Mark …